Detalhe da pesquisa
1.
Pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer (MyPathway): an updated report from a multicentre, open-label, phase 2a, multiple basket study.
Lancet Oncol
; 20(4): 518-530, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30857956
2.
Retrospective Analysis of Taxane-Based Therapy in Small Bowel Adenocarcinoma.
Oncologist
; 24(6): e384-e386, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30598498
3.
Obesity Early in Adulthood Increases Risk but Does Not Affect Outcomes of Hepatocellular Carcinoma.
Gastroenterology
; 149(1): 119-29, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25836985
4.
Joint prognostic effect of obesity and chronic systemic inflammation in patients with metastatic colorectal cancer.
Cancer
; 121(17): 2968-75, 2015 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25975416
5.
Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 study.
EClinicalMedicine
; 58: 101917, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-37090438
6.
Benchmarking Outcomes for Definitive Treatment of Young-Onset, Locally Advanced Rectal Cancer.
Clin Colorectal Cancer
; 21(1): e28-e37, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34794903
7.
Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial.
Lancet Gastroenterol Hepatol
; 7(3): 208-218, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35065057
8.
A review of electrocardiography in pulmonary embolism: recognizing pulmonary embolus masquerading as ST-elevation myocardial infarction.
Rev Cardiovasc Med
; 12(3): 157-63, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22145193
9.
A Prospective Phase II Study of Safety and Efficacy of Sorafenib Followed by 90Y Glass Microspheres for Patients with Advanced or Metastatic Hepatocellular Carcinoma.
J Hepatocell Carcinoma
; 8: 1129-1145, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34527608
10.
FBXW7 missense mutation: a novel negative prognostic factor in metastatic colorectal adenocarcinoma.
Oncotarget
; 8(24): 39268-39279, 2017 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-28424412
11.
Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma.
Onco Targets Ther
; 9: 773-80, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26929648
12.
Yttrium-90 resin microspheres as an adjunct to sorafenib in patients with unresectable hepatocellular carcinoma.
J Hepatocell Carcinoma
; 3: 1-7, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27574586
13.
From Protocols to Publications: A Study in Selective Reporting of Outcomes in Randomized Trials in Oncology.
J Clin Oncol
; 33(31): 3583-90, 2015 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26304898
14.
Role of HGF/MET axis in resistance of lung cancer to contemporary management.
Transl Lung Cancer Res
; 1(3): 179-93, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25806180
15.
Motesanib and advanced NSCLC: experiences and expectations.
Expert Opin Investig Drugs
; 20(6): 859-69, 2011 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-21534718